现代医药卫生2024,Vol.40Issue(7) :1230-1233,1238.DOI:10.3969/j.issn.1009-5519.2024.07.031

阿奇霉素在慢性气道疾病中对气道黏液高分泌作用的研究进展

Research progress on the effect of azithromycin on airway mucus hypersecretion in chronic airway diseases

王士佳 罗健
现代医药卫生2024,Vol.40Issue(7) :1230-1233,1238.DOI:10.3969/j.issn.1009-5519.2024.07.031

阿奇霉素在慢性气道疾病中对气道黏液高分泌作用的研究进展

Research progress on the effect of azithromycin on airway mucus hypersecretion in chronic airway diseases

王士佳 1罗健1
扫码查看

作者信息

  • 1. 重庆医科大学附属儿童医院呼吸科/国家儿童健康与疾病临床医学研究中心/儿童发育疾病研究教育部重点实验室/儿科代谢与炎症性疾病重庆市重点实验室,重庆 400014
  • 折叠

摘要

气道黏液高分泌是多种慢性气道疾病的重要病理生理及临床表现,是影响疾病预后及转归的独立危险因素.阿奇霉素可有效预防或减少慢性气道疾病急性加重,抑制慢性气道疾病气道黏液高分泌状态,但具体机制尚未完全明确,可能与阿奇霉素抑制黏蛋白MUC5AC的合成和分泌、抑制细菌生物膜形成等作用有关.该文总结了阿奇霉素抑制气道黏液高分泌的可能作用机制及其在慢性气道疾病的应用现状,以期为阿奇霉素的后续研究及临床应用提供诊疗参考.

Abstract

Airway mucus hypersecretion is an important pathophysiological and clinical manifestation of a variety of chronic airway diseases,and is an independent risk factor affecting the prognosis and outcome of the disease.Azithromycin can effectively prevent or reduce the acute exacerbation of chronic airway diseases and inhibit the hypersecretion of airway mucus in chronic airway diseases.However,the specific mechanism is not completely clear,which may be related to the inhibition of the synthesis and secretion of mucin MUC5AC and the inhibition of bacterial biofilm formation.This article summarizes the possible mechanism of azithro-mycin in inhibiting airway mucus hypersecretion and its application in chronic airway diseases,in order to pro-vide reference for the follow-up study and clinical application of azithromycin.

关键词

阿奇霉素/慢性气道疾病/气道黏液高分泌/MUC5AC/生物膜

Key words

Azithromycin/Chronic airway diseases/Airway mucus hypersecretory/MUC5AC/Biofilm

引用本文复制引用

出版年

2024
现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
参考文献量32
段落导航相关论文